mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.4 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.4 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
alvocidib |
CTRPv2 |
pan-cancer |
AAC |
-0.036 |
0.5 |
mRNA |
BRD1835 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |
mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.5 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.5 |